[1] |
Larcher A, Nini A, Fossatin N, et al. When to perform a staging chest-CT scan before surgical treatment for kidney cancer[J]. J Urology, 2016, 195(4): e962.
|
[2] |
Tan WCC, Nerurkar SN, Cai HY, et al. Overview of multiplex immunohistochemistry/ immunofluorescence techniques in the era of cancer immunotherapy[J]. Cancer Commun- (Lond), 2020, 40(4): 135-153.
|
[3] |
张新月, 陈慧娟, 白巧红, 等. 卡瑞丽珠单抗联合培美曲赛和顺铂治疗局部晚期非小细胞肺癌的临床观察及生存分析[J]. 中国肿瘤外科杂志, 2022, 14(6): 567-570, 575.
|
[4] |
Feller A, Matthes KL, Bordoni A, et al. The relative risk of second primary cancers in Switzerland: A population-based retrospective cohort study[J]. BMC Cancer, 2020, 20(1): 51-65.
|
[5] |
Tanjak P, Suktitipat B, Vorasan N, et al. Risks and cancer associations of metachronous and synchronous multiple primary cancers: A 25-year retrospective study[J]. BMC Cancer, 2021, 21(1): 1045-1054.
|
[6] |
Copur MS, Manapuram S. Multiple primary tumors over a lifetime[J]. Oncology (Williston Park), 2019, 33(7): 629384.
|
[7] |
Halamkova J, Kazda T, Pehalova L, et al. Second primary malignancies in colorectal cancer patients[J]. Sci Rep, 2021, 11(1): 2759.
|
[8] |
Liu C, Wang C, Du Z, et al. Clinical features and prognosis of duplex primary malignant neoplasms involving chronic myeloid leukemia[J]. Medicine (Baltimore), 2020, 99(44): e22904.
|
[9] |
Chen T, Fallah M, Brenner H, et al. Risk of second primary cancers in multiple myeloma survivors in german and swedish cancer registries[J]. Sci Rep, 2016, 6: 22084.
|
[10] |
何立儒, 董培, 高剑铭, 等. 今非昔比:放疗在肾癌中的发展现况[J]. 现代泌尿外科杂志, 2022, 27(1): 1-6.
|
[11] |
Pham D, Thompson A, Kron T, et a1. Stereotactic ablative body radiation therapy for primary kidney cancer:a 3-dimensional conformal technique associated with low rates of early toxicity[J]. Int J Radiat Oncol Biol Phys,2014, 90(5): 1061-1068.
|
[12] |
Chang JH, Cheung P, Eri.er D, et a1. Stereotactic ablative body radiotherapy for primary renal cell carcinoma in non-surgical candidates: initial clinical experience[J]. Clin Oncol(R Coll Radiol), 2016, 28(9): e109-e114.
|
[13] |
Hsieh JJ, Purdue MP, Signoretti S, et al. Renal cell carcinoma[J]. Nat Rev Dis Primers, 2017, 3: 17009.
|
[14] |
邱敏, 连岩岩, 陆敏, 等. 多原发癌合并肾癌的治疗及预后[J]. 北京大学学报(医学版), 2022, 54(4): 680-685.
|
[15] |
Beisland C, Talleraas O, Bakke A, et al. Multiple primary malignancies in patients with renal cell carcinoma: a national population-based cohort study[J]. BJU Int, 2006, 97(4): 698-702.
|
[16] |
张海梁, 叶定伟, 姚旭东, 等. 合并肾细胞癌的多原发恶性肿瘤临床分析[J]. 第三军医大学学报, 2009, 31(13): 1261-1263.
|
[17] |
Joung JY, Kwon WA, Lim J, et al. Second primary cancer risk among kidney cancer patients in Korea: a populationbased cohort study[J]. Cancer Res Treat, 2018, 50(1): 293-301.
|
[18] |
何敏, 蔡依玲, 王坚. 多原发恶性肿瘤的研究进展[J]. 癌症进展, 2023, 21(10): 1054-1056.
|
[19] |
连岩岩, 王丹, 陈琪, 等. 合并肾细胞癌的多原发恶性肿瘤9例临床分析[J]. 癌症进展. 2020, 18(8): 815-818.
|
[20] |
牛俊豪, 王俊勇, 张莹, 等. 泌尿男生殖系多原发恶性肿瘤临床分析[J]. 中华肿瘤防治杂志, 2015, 22(11): 181-182.
|
[21] |
付伟金, 丁强, 夏国伟. 肾转移癌的诊断和治疗(附6例报告并文献复习)[J]. 临床泌尿外科杂志, 2009, 24(2): 97-98.
|
[22] |
宋尚卿, 蔡晨, 王林辉, 等. 肺癌术后肾转移行患肾切除术2例报告[J]. 第二军医大学学报, 2013, 34(5): 579-580.
|